Navigation Links
Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
Date:11/9/2007

NEW YORK, Nov. 9 /Xinhua-PRNewswire-FirstCall/ -- Discas, Inc. (Pink Sheets: DSCS.PK), ("the Company") announced today that on November 6, 2007, it entered into a stock purchase agreement with SNX Organic Fertilizers, Inc., ("SNXOF"), a Delaware corporation. SNXOF's sole asset is Beijing Shen Nong Xing Technology Co. Ltd. ("BSNX"), a high-tech company headquartered in Beijing. The Company specializes in the research and development of green and organic agricultural products, including organic bio fertilizers, green agricultural products, and various organic health products.

As a result, SNXOF acquired 50.001% of the capital stock of the Company. Dr. Huakang Zhou, President and CEO of SNXOF was also nominated as the sole officer and director of the Company.

About Beijing Shen Nong Xing Technology Co. Ltd (SNX)

The Company, headquartered in Beijing with two manufacturing facilities -- Daqing Shen Nong Xing Xiangyu Technology Co. Ltd. located in Daqing City and Heilongjiang Shen Nong Xing Hongyu Fertilizer Co. Ltd. located in Huanan County, Heilongjiang province -- was registered under the laws of the Peoples' Republic of China. The Company specializes in the research and development, manufacture and sale of green and organic agricultural products, including organic bio fertilizers, green agricultural products, and various organic health products.

Safe Harbor Statement

The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


'/>"/>
SOURCE Discas, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
3. Neuralstem Shares Accepted for Trading on Amex(R)
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded ... of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for ... fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):